User profiles for C. O’Callaghan

Christopher O'Callaghan

- Verified email at ucl.ac.uk - Cited by 16865

Christopher J O'Callaghan

- Verified email at ctg.queensu.ca - Cited by 12204

Casey O'Callaghan

- Verified email at wustl.edu - Cited by 1887

[HTML][HTML] K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

…, DJ Jonker, CJ O'Callaghan… - … England Journal of …, 2008 - Mass Medical Soc
Background Treatment with cetuximab, a monoclonal antibody directed against the epidermal
growth factor receptor, improves overall and progression-free survival and preserves the …

[HTML][HTML] Global prevalence of chronic kidney disease–a systematic review and meta-analysis

NR Hill, ST Fatoba, JL Oke, JA Hirst, CA O'Callaghan… - PloS one, 2016 - journals.plos.org
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …

[HTML][HTML] Cetuximab for the treatment of colorectal cancer

DJ Jonker, CJ O'Callaghan, CS Karapetis… - … England Journal of …, 2007 - Mass Medical Soc
Background Cetuximab, an IgG1 chimeric monoclonal antibody against epidermal growth
factor receptor (EGFR), has activity against colorectal cancers that express EGFR. Methods …

Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate

CH O'Callaghan, A Morris, SM Kirby… - Antimicrobial agents …, 1972 - Am Soc Microbiol
A new cephalosporin with a highly reactive β-lactam ring was found to give an immediate
color change in the presence of β-lactamases from many bacteria, including staphylococci, …

[HTML][HTML] FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer

…, CJ O'Callaghan, C Jouffroy-Zeller… - … England Journal of …, 2018 - Mass Medical Soc
Background Among patients with metastatic pancreatic cancer, combination chemotherapy
with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall …

[HTML][HTML] Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and …

…, R Grieve, S Khanna, J Couture, C O'Callaghan… - The Lancet, 2009 - thelancet.com
Background Local recurrence rates in operable rectal cancer are improved by radiotherapy (with
or without chemotherapy) and surgical techniques such as total mesorectal excision. …

Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

…, GS Ogg, JDK Wilson, CA O'callaghan… - The Journal of …, 1998 - rupress.org
… 1, c and e, we again showed that PBLs taken from HLA-matched EBV-seronegative donors
or from HLA-mismatched EBV-seropositive donors gave no staining with the tetrameric …

[HTML][HTML] Short-course radiation plus temozolomide in elderly patients with glioblastoma

JR Perry, N Laperriere, CJ O'Callaghan… - … England Journal of …, 2017 - Mass Medical Soc
Background Glioblastoma is associated with a poor prognosis in the elderly. Survival has
been shown to increase among patients 70 years of age or younger when temozolomide …

Association of KRAS p. G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab

…, H Piessevaux, E Van Cutsem, CJ O'Callaghan… - Jama, 2010 - jamanetwork.com
Context Patients with metastatic colorectal cancer who have KRAS codon 12– or KRAS codon
13–mutated tumors are presently excluded from treatment with the anti–epidermal growth …

[BOOK][B] Sounds: A philosophical theory

C O'Callaghan - 2007 - books.google.com
… established practice, Casey O'Callaghan provides a systematic … secondary or sensible
qualities, O'Callaghan argues that, on any … O'Callaghan's account of sounds and their perception …